4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-006394
10% owner sold 50,000 shares at an average $34.73 ($1,736,352)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morningside Venture Investments Ltd 10% owner | 2023-02-22 | Sale | −47,888 | $34.70 | $1,661,714 | 7,532,710 | D |
| Morningside Venture Investments Ltd 10% owner | 2023-02-22 | Sale | −2,112 | $35.34 | $74,638 | 7,530,598 | D |
| Open-market sales · 50,000 sh · avg $34.73 · $1,736,352 | |||||||
Loading xslF345X03/doc4.xml…